Civic AI
Procurement intelligence
Federal contract award
BIOMERIEUX'S NUCLISENS REAGENTS TO BE USED ON THEIR SAMPLE EXTRACTION PLATFORMS THAT HAVE BEEN VALIDATED FOR HIV DRUG RESISTANCE: NUCLISENS EASYMAG, EMAG AND THE MINIMAG WHICH ARE USED BY THE MOLECULAR DIAGNOSTIC AND SURVEILLANCE TEAM'S SURVEILLANCE
BIOMERIEUX INC · Department of Health and Human Services
- Value
- $11,973
- Start
- Aug 20, 2024
- End
- Sep 11, 2024
- Action date
- Feb 25, 2026
- PIID
- 75D30124P00045
- Status
- completed
- NAICS
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- Place of performance
- SALT LAKE CITY, UT
- Award type
- PURCHASE ORDER
Description
BIOMERIEUX'S NUCLISENS REAGENTS TO BE USED ON THEIR SAMPLE EXTRACTION PLATFORMS THAT HAVE BEEN VALIDATED FOR HIV DRUG RESISTANCE: NUCLISENS EASYMAG, EMAG AND THE MINIMAG WHICH ARE USED BY THE MOLECULAR DIAGNOSTIC AND SURVEILLANCE TEAM'S SURVEILLANCE
Need modifications, related awards, and vendor peers? Open the full award workspace.